| Disease | gastroesophageal reflux disease |
| Symptom | C0027497|nausea |
| Sentences | 1 |
| PubMedID- 22882281 | As expected, given the supratherapeutic dosing, nausea, vomiting and symptoms of gastroesophageal reflux disease were most commonly associated with exenatide and were observed less frequently with placebo or moxifloxacin. |
Page: 1